Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hogan

Showing results (1261-1270 of 1,303) with videos related to

Pageof 131
Sort By:
Haematologica|June 6, 2020
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decadesJason P Cooper, Barry E Storer, Noa Granot, et al.
RMD Open|October 6, 2025
Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspectiveElena W Y Hsieh, James B Chung, Afsah Amin, et al.
Bone Marrow Transplantation|August 23, 2016
Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMTZ DeFilipp, R F Duarte, J A Snowden, et al.
Immunity|August 14, 2020
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in MiceDorottya Laczkó, Michael J Hogan, Sushila A Toulmin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2016
Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMTZachariah DeFilipp, Rafael F Duarte, John A Snowden, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 14, 2018
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular DiseaseLaura H Mariani, Andrew S Bomback, Pietro A Canetta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Hematopoietic stem-cell transplantation for advanced systemic mastocytosisCelalettin Ustun, Andreas Reiter, Bart L Scott, et al.
The Journal of Experimental Medicine|May 10, 2018
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responsesNorbert Pardi, Michael J Hogan, Martin S Naradikian, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2021
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney FoundationAndrew S Bomback, Gerald B Appel, Debbie S Gipson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 2, 2020
Identifying Outcomes Important to Patients with Glomerular Disease and Their CaregiversSimon A Carter, Talia Gutman, Charlotte Logeman, et al.
Pageof 131

Showing results (1261-1270 of 1,303) with videos related to

Sort By:
Pageof 131
Haematologica|June 6, 2020
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decadesJason P Cooper, Barry E Storer, Noa Granot, et al.
RMD Open|October 6, 2025
Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspectiveElena W Y Hsieh, James B Chung, Afsah Amin, et al.
Bone Marrow Transplantation|August 23, 2016
Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMTZ DeFilipp, R F Duarte, J A Snowden, et al.
Immunity|August 14, 2020
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in MiceDorottya Laczkó, Michael J Hogan, Sushila A Toulmin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2016
Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMTZachariah DeFilipp, Rafael F Duarte, John A Snowden, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 14, 2018
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular DiseaseLaura H Mariani, Andrew S Bomback, Pietro A Canetta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Hematopoietic stem-cell transplantation for advanced systemic mastocytosisCelalettin Ustun, Andreas Reiter, Bart L Scott, et al.
The Journal of Experimental Medicine|May 10, 2018
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responsesNorbert Pardi, Michael J Hogan, Martin S Naradikian, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2021
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney FoundationAndrew S Bomback, Gerald B Appel, Debbie S Gipson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 2, 2020
Identifying Outcomes Important to Patients with Glomerular Disease and Their CaregiversSimon A Carter, Talia Gutman, Charlotte Logeman, et al.
Pageof 131